E-drug: Re: Dipyrone
---------------------------------------------
The situation in Germany is as follows:
In April 1987 most dipyrone combinations were banned. In
February 1990 the German authority (BGA) finally withdraw all
licenses for dipyrone-combinations.
The use of dipyrone as single substance has been severely
restricted 1 March 1987 to "the treatment of acute severe pain
after injuries or surgery, colics, tumor pain and other acute
severe states of pain, if other therapeutic management is
insufficient". Fever may only be treated with dipyrone if all other
therapeutic measures fail. The BGA took the IAAAS study into
account in its decision and judged "The study design chosen in
the IAAAS is not suitable to yield data about absolute risks". All
these measures have been taken on the risk intervention
scheme (Stufenplan). A final assessment about dipyrone's
effects and risks based on the 1978 drugs law is still pending.
Dipyrone has prescription only status.
The scientific discussion about dipyrone was summarised by
BUKO and HAI-Europe some years ago. Anyone interested can
ask HAI for a copy of "Dipyrone - a drug NO one needs" email
hai@hai.antenna.nl
I posted a comment on the re-licensing of <Dipyrone in
in e-drug 7.10.1997.
Jorg Schaaber
BUKO Pharma-Kampagne, August-Bebel-Str. 62, D-33602
Bielefeld, Germany
Phone +49-521-60550 Fax +49-521-63789 email:
bukopharma@compuserve.com
homepage: www.epo.de/bukopharma/
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.